Article
Barriers And Facilitators For Therapeutic Drug Monitoring Of Beta-Lactams And Ciprofloxacin In The ICU: A Nationwide Cross-Sectional Study
2022-02-28
Abstract excerpt
<h4>Background: </h4> Recent studies demonstrated that failure of achieving pharmacodynamic targets of commonly used antibiotics is common in critically ill patients. Therapeutic drug monitoring (TDM) can contribute to optimize the exposure of beta-lactams and ciprofloxacin. While evidence for TDM of these antibiotics is growing, translation into clinical implementation remains limited. Therefore, perceived barrie...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fbeb7a3e-9296-5ffb-bf6c-3b55fbef7fd2
- DOI
- 10.21203/rs.3.rs-1213794/v1
